Assignee
GENEXA INC
US·1 granted patent·6 pending applications·0 citations·filing 2021–2024
Top patents by PatentIndex Score
7 records- 0181US2025090669A1Pharmaceutical syrup formulation or suspensionGENEXA INC·Filed 2024·Application pending·0 cites
- 0280US2025000984A1Diphenhydramine syrup formulation or suspensionGENEXA INC·Filed 2024·Application pending·0 cites
- 0378US2024415971A1Dextromethorphan and guaifenesin syrup formulationGENEXA INC·Filed 2024·Application pending·0 cites
- 0473US11931413B2Dextromethorphan and guaifenesin syrup formulation or suspensionGENEXA INC·Filed 2022·Granted Mar 19, 2024·0 cites·25 claims
- 0560US2024226038A9Solid pharmaceutical tabletGENEXA INC·Filed 2022·Application pending·0 cites
- 0653US2024130974A1Solid pharmaceutical tabletGENEXA INC·Filed 2022·Application pending·0 cites
- 0748US2022040097A1Chewable tabletGENEXA INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENEXA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →